High‐grade sarcoma diagnosis and prognosis: Biomarker discovery by mass spectrometry imaging

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Proteomics

• Publication date

  2016-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/pmic.201500514PMID 27174013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Imaging Mass Spectrometry

  2017cited by this paper
• Deep learning and 3D-DESI imaging reveal the hidden metabolic heterogeneity of cancer

  2017cited by this paper
• De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry

  2015cited by this paper
• Large-Scale Mass Spectrometry Imaging Investigation of Consequences of Cortical Spreading Depression in a Transgenic Mouse Model of Migraine

  2015cited by this paper
• MSiMass list: a public database of identifications for protein MALDI MS imaging.

  2014cited by this paper
• Gene Expression Profiling in Leiomyosarcomas and Undifferentiated Pleomorphic Sarcomas: SRC as a New Diagnostic Marker

  2014cited by this paper
• Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma.

  2014cited by this paper
• International expert opinion on patient-tailored management of soft tissue sarcomas.

  2014cited by this paper
• MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays.

  2014cited by this paper
• Macrophage Migration Inhibitory Factor and Stearoyl-CoA Desaturase 1: Potential Prognostic Markers for Soft Tissue Sarcomas Based on Bioinformatics Analyses

  2013influential reference
• Antiangiogenic approach in soft-tissue sarcomas

  2013cited by this paper
• Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas

  2013cited by this paper
• Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria

  2013cited by this paper
• Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies

  2013cited by this paper
• Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas

  2013cited by this paper
• MALDI imaging on large‐scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer

  2013cited by this paper
• Potential tumor markers of renal cell carcinoma: α‐Enolase for postoperative follow up, and galectin‐1 and galectin‐3 for primary detection

  2013cited by this paper
• The impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) in human breast cancer

  2013cited by this paper
• WHO classification of tumours of soft tissue and bone

  2013cited by this paper
• MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large‐scale tissue microarrays

  2013cited by this paper
• Comprehensive Identification of Proteins from MALDI Imaging*

  2013cited by this paper
• MALDI imaging of post‐mortem human spinal cord in amyotrophic lateral sclerosis

  2013cited by this paper
• Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions.

  2012cited by this paper
• The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: evidence from mass spectrometry profiling

  2012cited by this paper
• Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions.

  2012cited by this paper
• Clonal evolution in cancer

  2012cited by this paper
• MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma.

  2012cited by this paper
• Advances in sarcoma genomics and new therapeutic targets

  2011cited by this paper
• Multiple Statistical Analysis Techniques Corroborate Intratumor Heterogeneity in Imaging Mass Spectrometry Datasets of Myxofibrosarcoma

  2011cited by this paper
• Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.

  2011cited by this paper
• CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients

  2011cited by this paper
• S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI Imaging

  2011cited by this paper
• MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer.

  2011cited by this paper
• Protein signatures for survival and recurrence in metastatic melanoma.

  2011cited by this paper
• Imaging mass spectrometry data reduction: Automated feature identification and extraction

  2010cited by this paper
• Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity

  2010cited by this paper
• Molecular imaging by mass spectrometry — looking beyond classical histology

  2010cited by this paper
• Peptide and protein imaging mass spectrometry in cancer research.

  2010cited by this paper
• Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.

  2010cited by this paper
• Clonal evolution in cancer

  2010cited by this paper
• Imaging Mass Spectrometry of a Specific Fragment of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase 2 Discriminates Cancer from Uninvolved Prostate Tissue

  2009cited by this paper
• Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?

  2009cited by this paper
• High‐throughput proteomic analysis of formalin‐fixed paraffin‐embedded tissue microarrays using MALDI imaging mass spectrometry

  2008influential reference
• Imaging mass spectrometry.

  2007cited by this paper
• Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker.

  2007cited by this paper
• LIMPIC: a computational method for the separation of protein MALDI-TOF-MS signals from noise

  2007cited by this paper
• Molecular Assessment of the Tumor Protein Microenvironment Using Imaging Mass Spectrometry

  2006cited by this paper
• Cancer diagnosis marker extraction for soft tissue sarcomas based on gene expression profiling data by using projective adaptive resonance theory (PART) filtering method

  2006cited by this paper
• Identification of hemoglobin‐α and ‐β subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer

  2005cited by this paper
• Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.

  2001cited by this paper

• Histological Grade, Tumor Breadth, and Hypertension Predict Early Recurrence in Pediatric Sarcoma: A LASSO-Regularized Micro-Cohort Study

  2025cites this paper
• Mass spectrometry in animal health laboratories: recent history, current applications, and future directions

  2024cites this paper
• Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy

  2024cites this paper
• Advancing rare cancer research by MALDI mass spectrometry imaging: Applications, challenges, and future perspectives in sarcoma

  2024cites this paper
• Establishing biomarkers for soft tissue sarcomas

  2024cites this paper
• Novel biomarkers in bone sarcomas — diagnosis, treatment selection, and clinical trials

  2024cites this paper
• Quantitative proteomic studies addressing unmet clinical needs in sarcoma

  2023cites this paper
• Mass spectrometry imaging in gynecological cancers: the best is yet to come

  2022cites this paper
• Emerging Computational Methods in Mass Spectrometry Imaging

  2022cites this paper
• Mass spectrometry-based chemical mapping and profiling toward molecular understanding of diseases in precision medicine

  2021cites this paper
• Molecular tissue profiling by MALDI imaging: recent progress and applications in cancer research

  2021cites this paper
• Toward clinical imaging mass spectrometry

  2021cites this paper
• Metabolic landscapes in sarcomas

  2021cites this paper
• Plasma Metabolomics Analysis of Polyvinyl Chloride Workers Identifies Altered Processes and Candidate Biomarkers for Hepatic Hemangiosarcoma and Its Development

  2021cites this paper
• Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities

  2020cites this paper
• Increasing Complexity to Simplify Clinical Care: High Resolution Mass Spectrometry as an Enabler of AI Guided Clinical and Therapeutic Monitoring

  2020cites this paper
• Molecular signatures of tumor progression in myxoid liposarcoma identified by N-glycan mass spectrometry imaging

  2020cites this paper
• The status of proteomics as we enter the 2020s: Towards personalised/precision medicine.

  2020cites this paper
• Automated biomarker candidate discovery in imaging mass spectrometry data through spatially localized Shapley additive explanations

  2020cites this paper
• Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri

  2019cites this paper
• Development and evaluation of matrix application techniques for high throughput mass spectrometry imaging of tissues in the clinic.

  2019cites this paper
• The Importance of Clinical Tissue Imaging.

  2019cites this paper
• In situ metabolomics in cancer tissue by high-resolution mass spectrometry imaging

  2019cites this paper
• Proteomic research in sarcomas – current status and future opportunities

  2019cites this paper
• Tissue and plasma proteomics for early stage cancer detection.

  2018cites this paper
• Analysis of three dimensional cell cultures using mass spectrometry imaging

  2018cites this paper
• An experimental guideline for the analysis of histologically heterogeneous tumors by MALDI-TOF mass spectrometry imaging.

  2017cites this paper
• Proteomic profiling of human plasma for cancer biomarker discovery

  2017cites this paper
• MALDI imaging mass spectrometry - From bench to bedside.

  2017cites this paper
• Network analysis of mass spectrometry imaging data from colorectal cancer identifies key metabolites common to metastatic development

  2017cites this paper
• Mass Spectrometry Imaging for the Investigation of Intratumor Heterogeneity.

  2017cites this paper
• Mass spectrometry imaging for clinical research - latest developments, applications, and current limitations.

  2017cites this paper
• Deep learning and 3D-DESI imaging reveal the hidden metabolic heterogeneity of cancer

  2017cites this paper
• Clinical applications of MALDI imaging technologies in cancer and neurodegenerative diseases.

  2017cites this paper
• Current status of proteomics of soft tissue sarcomas

  2017cites this paper
• High nuclear expression of proteasome activator complex subunit 1 predicts poor survival in soft tissue leiomyosarcomas

  2016cites this paper
• Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging

  2016cites this paper